275 related articles for article (PubMed ID: 31285356)
21. Eat, Sleep, Console and Adjunctive Buprenorphine Improved Outcomes in Neonatal Opioid Withdrawal Syndrome.
Hein S; Clouser B; Tamim MM; Lockett D; Brauer K; Cooper L
Adv Neonatal Care; 2021 Feb; 21(1):41-48. PubMed ID: 33278102
[TBL] [Abstract][Full Text] [Related]
22. A quality improvement project to reduce length of stay for neonatal abstinence syndrome.
Asti L; Magers JS; Keels E; Wispe J; McClead RE
Pediatrics; 2015 Jun; 135(6):e1494-500. PubMed ID: 25941308
[TBL] [Abstract][Full Text] [Related]
23. Neonatal Abstinence Syndrome: Prevention, Recognition, Treatment, and Follow-up.
Schroeder M; White J
S D Med; 2021 Dec; 74(12):576-583. PubMed ID: 35015949
[TBL] [Abstract][Full Text] [Related]
24. Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population.
Lee J; Hulman S; Musci M; Stang E
Popul Health Manag; 2015 Oct; 18(5):392-7. PubMed ID: 25803316
[TBL] [Abstract][Full Text] [Related]
25. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
26. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal.
Young LW; Ounpraseuth ST; Merhar SL; Hu Z; Simon AE; Bremer AA; Lee JY; Das A; Crawford MM; Greenberg RG; Smith PB; Poindexter BB; Higgins RD; Walsh MC; Rice W; Paul DA; Maxwell JR; Telang S; Fung CM; Wright T; Reynolds AM; Hahn DW; Ross J; McAllister JM; Crowley M; Shaikh SK; Puopolo KM; Christ L; Brown J; Riccio J; Wong Ramsey K; Akshatha ; Braswell EF; Tucker L; McAlmon KR; Dummula K; Weiner J; White JR; Howell MP; Newman S; Snowden JN; Devlin LA;
N Engl J Med; 2023 Jun; 388(25):2326-2337. PubMed ID: 37125831
[TBL] [Abstract][Full Text] [Related]
27. Eat, Sleep, Console Approach: A Family-Centered Model for the Treatment of Neonatal Abstinence Syndrome.
Grisham LM; Stephen MM; Coykendall MR; Kane MF; Maurer JA; Bader MY
Adv Neonatal Care; 2019 Apr; 19(2):138-144. PubMed ID: 30855311
[TBL] [Abstract][Full Text] [Related]
28. Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis.
MacMillan KDL; Rendon CP; Verma K; Riblet N; Washer DB; Volpe Holmes A
JAMA Pediatr; 2018 Apr; 172(4):345-351. PubMed ID: 29404599
[TBL] [Abstract][Full Text] [Related]
29. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
30. A Hospital-Level Intervention to Improve Outcomes of Opioid Exposed Newborns.
Cree M; Jairath P; May O
J Pediatr Nurs; 2019; 48():77-81. PubMed ID: 31352111
[TBL] [Abstract][Full Text] [Related]
31. Opioid Neonatal Abstinence Syndrome: An Overview.
Wexelblatt SL; McAllister JM; Nathan AT; Hall ES
Clin Pharmacol Ther; 2018 Jun; 103(6):979-981. PubMed ID: 29285767
[TBL] [Abstract][Full Text] [Related]
32. Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome.
Maalouf FI; Cooper WO; Slaughter JC; Dudley J; Patrick SW
J Pediatr; 2018 Aug; 199():151-157.e1. PubMed ID: 29754866
[TBL] [Abstract][Full Text] [Related]
33. Parent Perspectives on the Eat, Sleep, Console Approach for the Care of Opioid-Exposed Infants.
McRae K; Sebastian T; Grossman M; Loyal J
Hosp Pediatr; 2021 Apr; 11(4):358-365. PubMed ID: 33658244
[TBL] [Abstract][Full Text] [Related]
34. Nonopioid Management of Neonatal Abstinence Syndrome.
Boucher AM
Adv Neonatal Care; 2017 Apr; 17(2):84-90. PubMed ID: 28002062
[TBL] [Abstract][Full Text] [Related]
35. Proxy Finnegan Component Scores for Eat, Sleep, Console in a Cohort of Opioid-Exposed Neonates.
Curran M; Holt C; Arciero M; Quinlan J; Cox D; Craig A
Hosp Pediatr; 2020 Dec; 10(12):1053-1058. PubMed ID: 33199395
[TBL] [Abstract][Full Text] [Related]
36. Morphine and Methadone for Neonatal Abstinence Syndrome: A Systematic Review.
Slowiczek L; Hein DJ; Risoldi Cochrane Z; Gregory PJ
Neonatal Netw; 2018 Nov; 37(6):365-371. PubMed ID: 30567886
[TBL] [Abstract][Full Text] [Related]
37. Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome.
Howard MB; Schiff DM; Penwill N; Si W; Rai A; Wolfgang T; Moses JM; Wachman EM
Hosp Pediatr; 2017 Feb; 7(2):63-69. PubMed ID: 28137920
[TBL] [Abstract][Full Text] [Related]
38. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
39. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.
Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH
J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442
[TBL] [Abstract][Full Text] [Related]
40. Strategies to Successfully Implement an Eat, Sleep, Console Protocol.
Wortham SE; Bianchi AL
MCN Am J Matern Child Nurs; 2022 Jul-Aug 01; 47(4):182-188. PubMed ID: 35352687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
